Clinical Trial Update: HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study [Phase 2]

View source ↗

Summary

This is a Phase II open-label, single-arm trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with adebrelimab and apatinib as first-line tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING